|
⚲
|
| Keyboard |
| Huh Hoyoung
✚
|
|
|---|---|
| CIK # | 0001401267 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001401267] | |
| 4 | [0001401267] | |
| SC 13D | [0001401267] | |
| SC 13G | [0001401267] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Huh Hoyoung | Akari Therapeutics PLC | [2025-02-14] |
| Huh Hoyoung | Peak Bio Inc | [2023-03-21] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Huh Hoyoung | |
| Pliant Therapeutics Inc | |
| Morria Biopharmaceuticals PLC | |
| Peak Bio Inc | |
| Eidos Therapeutics Inc | |
| CytomX Therapeutics Inc | |
| Geron Corp | |
| FITS My Style Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Morria Biopharmaceuticals PLC AKTX
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
|
2025-12-16 | Buy | 618,658 | ||
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 618,658 | $0.40 | 247,463 |
|
Morria Biopharmaceuticals PLC AKTX
Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 3,093,293 | ||
|
Morria Biopharmaceuticals PLC AKTX
Pre-Funded Warrants to purchase ADRs · derivative
|
2025-12-16 | Buy | 3,093,293 | $0.40 | 1,237,317 |
|
Pliant Therapeutics Inc PLRX
Common Stock (Right to Buy) · derivative
|
2025-06-05 | Grant | 30,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 225,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Stock Option (Right to Buy) · derivative
|
2025-03-20 | Grant | 175,000 | $0.00 | |
|
Morria Biopharmaceuticals PLC AKTX
Series A Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 892,857 | $1.12 | 1,000,000 |
|
Morria Biopharmaceuticals PLC AKTX
American Depositary Shares representing Ordinary Shares
|
2025-03-06 | Grant | 892,857 | $1.12 | 1,000,000 |
|
Morria Biopharmaceuticals PLC AKTX
Series B Warrants (Right to Buy) · derivative
|
2025-03-06 | Grant | 892,857 | $1.12 | 1,000,000 |
|
Peak Bio Inc PKBO
Common Stock
|
2024-11-14 | Disposed to issuer | 4,574,661 | ||
|
Peak Bio Inc PKBO
Common Stock
|
2024-11-14 | Disposed to issuer | 372,940 | ||
|
Peak Bio Inc PKBO
Common Stock
|
2024-11-14 | Disposed to issuer | 8,382,742 | ||
|
Peak Bio Inc PKBO
Common Stock
|
2024-11-14 | Conversion | 4,574,661 | ||
|
Peak Bio Inc PKBO
Stock Option (Right to Buy) · derivative
|
2024-11-14 | Disposed to issuer | $0.00 | ||
|
Peak Bio Inc PKBO
Convertible Notes · derivative
|
2024-11-14 | Conversion | 176,292 | ||
|
Peak Bio Inc PKBO
Warrant (Right to Purchase) · derivative
|
2024-11-14 | Disposed to issuer | 1,200,000 | ||
|
Pliant Therapeutics Inc PLRX
Common Stock (Right to Buy) · derivative
|
2024-06-13 | Grant | 26,764 | $0.00 | |
|
Peak Bio Inc PKBO
Common Stock
|
2023-09-21 | Buy | 45,000 | ||
|
Peak Bio Inc PKBO
Common Stock
|
2023-09-20 | Buy | 30,000 | ||
| showing 20 of 75 most recent transactions | |||||